CN / EN
News center
About us

TechnoDerma Medicines Inc.

Technoderma Medicines, Inc. is a privately held clinical stage biopharmaceutical company. The Company was originally locatedin Jiaxing Xiuzhou Biomedicine Guoqian Park, China,and recently relocated to Chengdu Biomed Town, Chengdu, Sichuan Province, China.

Its current core programs focus on development of innovative therapies for Androgenetic Alopecia, Atopic Dermatitis, Psoriasis and Lupus Erythematosus. Its "first-in-class" small molecule thyromimetic drug candidate TDM-105795 for Androgenetic Alopecia is currently in Phase 2a clinical testing. Technoderma’s novel JAK1/TYK2 inhibitor TDM-180935 for Atopic Dermatitis is now in Phase 1 clinical testing. The pipeline targets dermatologic indications.


看国产一级片,国产伦精品一区二区三区高清,欧美一区二区在线免费观看,国产99精品免费视频看6